Manufacturing and Production

Showing 15 posts of 5860 posts found.

FDA warns Teva over California plant

April 30, 2010 Manufacturing and Production Teva, manufacturing compliance

Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …
Frazier

Merck separates president role, appoints Kenneth Frazier

April 30, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing

Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
Robert_Bradway

Amgen promotes Robert Bradway to president

April 28, 2010 Manufacturing and Production, Sales and Marketing Amgen, appointment, manufacturing and production, sales and marketing

Robert Bradway has been appointed president and chief operating officer at US biotech Amgen. Bradway, currently executive VP and chief …

Recovery signs, but outsourcing gets more competitive

April 26, 2010 Manufacturing and Production, Research and Development Interphex, contract manufacturing, contract research, contract research organisation

The first green shoots of  recovery in the global economy – assuming of course they are not going to be …

New manufacturing products launched at Interphex

April 26, 2010 Manufacturing and Production Interphex, manufacturing and production, manufacturing equipment

The annual Interphex exhibition in New York was somewhat low-key this year with attendance disrupted by the block on flights …
Paula Staples

Paula Staples joins Owen Mumford

April 23, 2010 Manufacturing and Production Owen Mumford, appointment, manufacturing and production

UK medical device manufacturer Owen Mumford has appointed Paula Staples as global head of quality.She joins from pharma company Abbott, …
Genzyme

Genzyme fined $175m for manufacturing problems

April 22, 2010 Manufacturing and Production Cerezyme, Cerezyme Fabrazyme Gaucher's Genzyme, Fabrazyme, Gaucher's, Genzyme, manufacturing compliance

The FDA seems to have lost patience with biotechnology company Genzyme over contamination problems at its manufacturing facilities, levying a …

Volcanic ash fallout hits pharma

April 21, 2010 Manufacturing and Production Clinical Supply Operations, disaster, logistics, supply chain

The headline news in the wake of the Icelandic volcano eruption has been of stranded passengers struggling to get home …

Third Apotex plant cited in FDA warning letter

April 19, 2010 Manufacturing and Production Apotex, generics, manufacturing compliance

Canada’s Apotex has been sent a warning letter citing manufacturing violations at a facility in Toronto that are identical to …

Pharma manufacturing news in brief

April 16, 2010 Manufacturing and Production

A round-up of news in the pharmaceutical manufacturing arena includes the removal of CFC-based MDIs from the US market, facility …

Hikma expands in Middle East & North Africa

April 15, 2010 Manufacturing and Production, Sales and Marketing Hikma, em

UK-headquartered Hikma Pharmaceuticals has signed a flurry of deals that expand its position in the fast-growing Middle East and North …

Reprieve for GSK workers as NY plant closure is cancelled

April 13, 2010 Manufacturing and Production GSK

The jobs of up to 210 workers at a GlaxoSmithKline plant in New York, USA, have been saved after the …
EAASMMikeIsles

Mike Isles joins EAASM

April 9, 2010 Manufacturing and Production EAASM, appointment, manufacturing and production, supply chain

The European Alliance for Access to Safe Medicines (EAASM) has appointed Mike Isles executive director. He was most recently at …

Genentech opens $400m fill-and-finish plant

April 8, 2010 Manufacturing and Production Genentech

US biotech giant Genentech has officially opened its new 296,000 sq. ft. biologics manufacturing facility in Hillsboro, near Portland, Oregon. …

Sigma-Aldrich opens large-scale high-potency unit

April 7, 2010 Manufacturing and Production Sigma-Aldrich

Sigma-Aldrich has increased its high-potency active pharmaceutical ingredient (HPAPI) production capacity with the opening of a newly-expanded facility that is …
The Gateway to Local Adoption Series

Latest content